- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.98 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 4 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
PIO.2: 9 residues within 4Å:- Chain A: K.15, L.40, K.41, W.42, R.43, K.145, Q.148, K.150, K.151
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:W.42, A:R.43, A:Q.148
- Salt bridges: A:K.15, A:K.145, A:K.150, A:K.150, A:K.151
PIO.9: 9 residues within 4Å:- Chain B: K.15, L.40, K.41, W.42, R.43, K.145, Q.148, K.150, K.151
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:W.42, B:R.43, B:Q.148
- Salt bridges: B:K.15, B:K.145, B:K.150, B:K.150, B:K.151
PIO.16: 9 residues within 4Å:- Chain C: K.15, L.40, K.41, W.42, R.43, K.145, Q.148, K.150, K.151
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:W.42, C:R.43, C:Q.148
- Salt bridges: C:K.15, C:K.145, C:K.150, C:K.150, C:K.151
PIO.23: 9 residues within 4Å:- Chain D: K.15, L.40, K.41, W.42, R.43, K.145, Q.148, K.150, K.151
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:W.42, D:R.43, D:Q.148
- Salt bridges: D:K.15, D:K.145, D:K.150, D:K.150, D:K.151
- 20 x K: POTASSIUM ION(Non-covalent)
K.3: 15 residues within 4Å:- Chain A: G.107, Y.108
- Chain B: G.107, Y.108
- Chain C: G.107, Y.108
- Chain D: G.107, Y.108
- Ligands: K.4, K.10, K.11, K.17, K.18, K.24, K.25
Ligand excluded by PLIPK.4: 19 residues within 4Å:- Chain A: I.106, G.107
- Chain B: I.106, G.107
- Chain C: I.106, G.107
- Chain D: I.106, G.107
- Ligands: K.3, K.5, K.10, K.11, K.12, K.17, K.18, K.19, K.24, K.25, K.26
Ligand excluded by PLIPK.5: 19 residues within 4Å:- Chain A: T.105, I.106
- Chain B: T.105, I.106
- Chain C: T.105, I.106
- Chain D: T.105, I.106
- Ligands: K.4, K.6, K.11, K.12, K.13, K.18, K.19, K.20, K.25, K.26, K.27
Ligand excluded by PLIPK.6: 11 residues within 4Å:- Chain A: T.105
- Chain B: T.105
- Chain C: T.105
- Chain D: T.105
- Ligands: K.5, K.12, K.13, K.19, K.20, K.26, K.27
Ligand excluded by PLIPK.7: 3 residues within 4Å:- Chain A: Y.217
- Ligands: K.21, K.28
Ligand excluded by PLIPK.10: 15 residues within 4Å:- Chain A: G.107, Y.108
- Chain B: G.107, Y.108
- Chain C: G.107, Y.108
- Chain D: G.107, Y.108
- Ligands: K.3, K.4, K.11, K.17, K.18, K.24, K.25
Ligand excluded by PLIPK.11: 19 residues within 4Å:- Chain A: I.106, G.107
- Chain B: I.106, G.107
- Chain C: I.106, G.107
- Chain D: I.106, G.107
- Ligands: K.3, K.4, K.5, K.10, K.12, K.17, K.18, K.19, K.24, K.25, K.26
Ligand excluded by PLIPK.12: 19 residues within 4Å:- Chain A: T.105, I.106
- Chain B: T.105, I.106
- Chain C: T.105, I.106
- Chain D: T.105, I.106
- Ligands: K.4, K.5, K.6, K.11, K.13, K.18, K.19, K.20, K.25, K.26, K.27
Ligand excluded by PLIPK.13: 11 residues within 4Å:- Chain A: T.105
- Chain B: T.105
- Chain C: T.105
- Chain D: T.105
- Ligands: K.5, K.6, K.12, K.19, K.20, K.26, K.27
Ligand excluded by PLIPK.14: 3 residues within 4Å:- Chain B: Y.217
- Ligands: K.21, K.28
Ligand excluded by PLIPK.17: 15 residues within 4Å:- Chain A: G.107, Y.108
- Chain B: G.107, Y.108
- Chain C: G.107, Y.108
- Chain D: G.107, Y.108
- Ligands: K.3, K.4, K.10, K.11, K.18, K.24, K.25
Ligand excluded by PLIPK.18: 19 residues within 4Å:- Chain A: I.106, G.107
- Chain B: I.106, G.107
- Chain C: I.106, G.107
- Chain D: I.106, G.107
- Ligands: K.3, K.4, K.5, K.10, K.11, K.12, K.17, K.19, K.24, K.25, K.26
Ligand excluded by PLIPK.19: 19 residues within 4Å:- Chain A: T.105, I.106
- Chain B: T.105, I.106
- Chain C: T.105, I.106
- Chain D: T.105, I.106
- Ligands: K.4, K.5, K.6, K.11, K.12, K.13, K.18, K.20, K.25, K.26, K.27
Ligand excluded by PLIPK.20: 11 residues within 4Å:- Chain A: T.105
- Chain B: T.105
- Chain C: T.105
- Chain D: T.105
- Ligands: K.5, K.6, K.12, K.13, K.19, K.26, K.27
Ligand excluded by PLIPK.21: 3 residues within 4Å:- Chain C: Y.217
- Ligands: K.7, K.14
Ligand excluded by PLIPK.24: 15 residues within 4Å:- Chain A: G.107, Y.108
- Chain B: G.107, Y.108
- Chain C: G.107, Y.108
- Chain D: G.107, Y.108
- Ligands: K.3, K.4, K.10, K.11, K.17, K.18, K.25
Ligand excluded by PLIPK.25: 19 residues within 4Å:- Chain A: I.106, G.107
- Chain B: I.106, G.107
- Chain C: I.106, G.107
- Chain D: I.106, G.107
- Ligands: K.3, K.4, K.5, K.10, K.11, K.12, K.17, K.18, K.19, K.24, K.26
Ligand excluded by PLIPK.26: 19 residues within 4Å:- Chain A: T.105, I.106
- Chain B: T.105, I.106
- Chain C: T.105, I.106
- Chain D: T.105, I.106
- Ligands: K.4, K.5, K.6, K.11, K.12, K.13, K.18, K.19, K.20, K.25, K.27
Ligand excluded by PLIPK.27: 11 residues within 4Å:- Chain A: T.105
- Chain B: T.105
- Chain C: T.105
- Chain D: T.105
- Ligands: K.5, K.6, K.12, K.13, K.19, K.20, K.26
Ligand excluded by PLIPK.28: 3 residues within 4Å:- Chain D: Y.217
- Ligands: K.7, K.14
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Whorton, M.R. et al., Crystal Structure of the Mammalian GIRK2 K(+) Channel and Gating Regulation by G Proteins, PIP(2), and Sodium. Cell(Cambridge,Mass.) (2011)
- Release Date
- 2011-10-12
- Peptides
- G protein-activated inward rectifier potassium channel 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.98 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NA: SODIUM ION(Non-functional Binders)
- 4 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
- 20 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Whorton, M.R. et al., Crystal Structure of the Mammalian GIRK2 K(+) Channel and Gating Regulation by G Proteins, PIP(2), and Sodium. Cell(Cambridge,Mass.) (2011)
- Release Date
- 2011-10-12
- Peptides
- G protein-activated inward rectifier potassium channel 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A - Membrane
-
We predict this structure to be a membrane protein.